Velsera(@velseraofficial) 's Twitter Profile Photo

Teaming up with Solaris Health, we've made genetic testing more accessible for urology patients nationwide. Watch how our collaboration with Integrated Medical Professionals, brings best-in-class therapeutics and in-house hereditary cancer testing.

account_circle
Samuel Kareff, MD, MPH(@SamuelKareffMD) 's Twitter Profile Photo

Bryan Schneider poses several limitations of relying on NGS for germline genetic testing:
What if gene pathogenicity is not updated?
What if the gene is not tested?
This tool is not yet ready to replace genetic testing

Bryan Schneider poses several limitations of relying on NGS for germline genetic testing: 
What if gene pathogenicity is not updated? 
What if the gene is not tested? 
This tool is not yet ready to replace genetic testing #germlinetesting #NGS #precisiononcology #LCSM #ASCO23
account_circle
Oncology News Australia(@OncologyNewsAus) 's Twitter Profile Photo

NEW : Introducing our latest podcast 'Genetics Masterclass with Dr Hilda High'

Apple: t.ly/QYA-9
Google: t.ly/7FULQ
Spotify: t.ly/ZA5C3
Oncology News: t.ly/tDzko

account_circle
Dr. Arora(@SanjeevaniArora) 's Twitter Profile Photo

On the way to CGA-IGC annual meeting ! Looking forward to learning and meeting colleagues. Super excited to give a talk on Research Committee’s findings on in 👇🏽👇🏽👇🏽👇🏽👇🏽👇🏽👇🏽

On the way to @CGAIGC annual meeting #CGAIGC23 #LasVegas! Looking forward to learning and meeting colleagues. Super excited to give a talk on Research Committee’s findings on #Universal #GermlineTesting in #ColorectalCancer 👇🏽👇🏽👇🏽👇🏽👇🏽👇🏽👇🏽
account_circle
Ed Esplin, MD, PhD(@EdEsplin) 's Twitter Profile Photo

Real-World Breast Surgery Utilization among with VUS -
9K , breast surgical procedure uptake by w/ VUS vs Negative results NOT signficantly different...

VUS results do not appear to prompt guideline-discordant…

Real-World Breast Surgery Utilization among #BreastCancer #Patients with #GermlineTesting VUS - 
9K #patients, breast surgical procedure uptake by #patients w/ VUS vs Negative results NOT signficantly different...

VUS results do not appear to prompt guideline-discordant…
account_circle
Steven Artandi, MD, PhD(@SCIDirector) 's Twitter Profile Photo

SCI member Allison Kurian and team found that only 6.8% of cancer patients underwent . This was especially true among Asian, Black, and Hispanic patients. bit.ly/3qsLhUm

SCI member @AllisonKurian and team found that only 6.8% of cancer patients underwent #GermlineTesting. This was especially true among Asian, Black, and Hispanic patients. bit.ly/3qsLhUm #CancerGeneticTesting
account_circle
Samuel Kareff, MD, MPH(@SamuelKareffMD) 's Twitter Profile Photo

When we find it, however, we should act! Timothy Yap reviews evidence that gBRCA1/2m demonstrate responses to PARPi, even beyond BRCA1/2-associated cancers.

Eagerly await finalized results of and other basket trials!

When we find it, however, we should act! Timothy Yap reviews evidence that gBRCA1/2m demonstrate responses to PARPi, even beyond BRCA1/2-associated cancers.

Eagerly await finalized results of #TAPUR and other basket trials! 

#hereditarycancer #germlinetesting #ASCO23
account_circle
Myriad Genetics(@myriadgenetics) 's Twitter Profile Photo

Lauren Sferrazza MS, LGC (Lauren Giannetti Sferrazza MS, LGC), Oncology MSL Manager at Myriad, on how the ASCO-Society of Surgical Oncology guideline update is an important step forward in advancing the use of genomics in clinical care for patients with breast cancer.

account_circle
CTOAM(@CTOAM) 's Twitter Profile Photo

How to get better cancer treatment with – NEW research!

Can this type of genetic testing help you get better cancer treatment?

This is something that our team has been doing for the past 10 years with our patients!

Learn more here:
buff.ly/3Scw16n

How to get better cancer treatment with #germlinetesting – NEW research!

Can this type of genetic testing help you get better cancer treatment?

This is something that our team has been doing for the past 10 years with our patients!

Learn more here:
buff.ly/3Scw16n
account_circle
Myriad Genetics(@myriadgenetics) 's Twitter Profile Photo

Neil Mariados, Radiation Oncologist at Cancer Care of Western New York, on how helps him and his patients discover the unknown about their diagnosis. Learn more: myriad.com/urology/provid…

account_circle
JCO Precision Oncology(@JCOPO_ASCO) 's Twitter Profile Photo

🧪 A clinical practice survey identified that a majority of hereditary experts support universal for all newly diagnosed patients with colorectal cancer. ➡️ brnw.ch/21wFigm

🧪 A clinical practice survey identified that a majority of hereditary #ColorectalCancer experts support universal #GermlineTesting for all newly diagnosed patients with colorectal cancer. ➡️ brnw.ch/21wFigm #crcsm
account_circle
JCO Oncology Practice(@JCOOP_ASCO) 's Twitter Profile Photo

A hybrid oncologist/genetic counselor–delivered model is a feasible for high-volume in men w  (both in person & via 💻); it does not eliminate racial disparities in testing access however. 👉 fal.cn/3vqSW Daniel Kwon MD

A hybrid oncologist/genetic counselor–delivered model is a feasible for high-volume #germlinetesting in men w #prostateCancer #pcSM (both in person & via #telehealth 💻); it does not eliminate racial disparities in testing access however. 👉 fal.cn/3vqSW @danielkwonmd
account_circle
JCO Precision Oncology(@JCOPO_ASCO) 's Twitter Profile Photo

‼️ Simultaneous Publication in by Linda Rodgers-Fouche, MGC, CGC et al: Exploring Stakeholders’ Perspectives on Implementing Universal for Colorectal Cancer: Findings From a Clinical Practice Survey ➡️ brnw.ch/21wDX5H

‼️ #CGAIGC23 Simultaneous Publication in #JCOPO by Linda Rodgers-Fouche, MGC, CGC et al: Exploring Stakeholders’ Perspectives on Implementing Universal #GermlineTesting for Colorectal Cancer: Findings From a Clinical Practice Survey ➡️ brnw.ch/21wDX5H #crcsm
account_circle
JCO Precision Oncology(@JCOPO_ASCO) 's Twitter Profile Photo

👀 Check out what just published in :

Exploring Stakeholders' Perspectives on Implementing Universal for Colorectal Cancer ➡️ brnw.ch/21wE8gb

👀 Check out what just published in #JCOPO: 

Exploring Stakeholders' Perspectives on Implementing Universal #GermlineTesting for Colorectal Cancer ➡️ brnw.ch/21wE8gb #crcsm
account_circle
Vivek Subbiah, MD(@VivekSubbiah) 's Twitter Profile Photo

⚡️ 👉Thrilled that our paper was one of the most talked about papers in the Journal of Clinical Oncology ! Journal of Clinical Oncology ASCO 👉
✅Universal and Tumor Needed to Win the War Against Cancer: Is the Diagnosis🎯🧬…

⚡️ #Sundaymotivation 👉Thrilled that our paper was one of the most talked about papers in the Journal of Clinical Oncology !   @JCO_ASCO @ASCO   👉
✅Universal #GermlineTesting and Tumor #GenomicTesting Needed to Win the War Against Cancer: #Genomics Is the Diagnosis🎯🧬…
account_circle
JIPO Editors(@JIPOEditors) 's Twitter Profile Photo

Recent research article by Meric-Bernstam et al. evaluates the number of patients with P/LPVs in BRCA1/2, then determines the germline testing outcomes doi.org/10.36401/JIPO-…

Recent #JIPO research article by Meric-Bernstam et al. evaluates the number of patients with P/LPVs in BRCA1/2, then determines the germline testing outcomes doi.org/10.36401/JIPO-… #germlinetesting #BRCA1 #BRCA2
account_circle